CINECA IRIS Institutional Research Information System

MANERA, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.488
EU - Europa 2.596
AS - Asia 1.350
SA - Sud America 43
OC - Oceania 30
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.431
IT - Italia 1.155
CN - Cina 566
SG - Singapore 410
IE - Irlanda 307
SE - Svezia 229
DE - Germania 159
FR - Francia 135
AT - Austria 131
FI - Finlandia 97
GB - Regno Unito 91
IN - India 78
VN - Vietnam 63
JP - Giappone 60
KR - Corea 48
CA - Canada 46
ES - Italia 46
NL - Olanda 42
UA - Ucraina 40
BE - Belgio 36
ID - Indonesia 34
BR - Brasile 26
PL - Polonia 24
AU - Australia 23
GR - Grecia 23
HK - Hong Kong 19
UZ - Uzbekistan 17
TR - Turchia 16
RU - Federazione Russa 12
MX - Messico 10
PT - Portogallo 10
CH - Svizzera 9
CZ - Repubblica Ceca 8
TW - Taiwan 8
BG - Bulgaria 7
CO - Colombia 7
NZ - Nuova Zelanda 7
RO - Romania 7
DK - Danimarca 6
PH - Filippine 6
EG - Egitto 5
IL - Israele 5
PE - Perù 5
TH - Thailandia 5
BY - Bielorussia 4
EU - Europa 4
IR - Iran 4
SN - Senegal 4
AL - Albania 3
HR - Croazia 3
HU - Ungheria 3
IQ - Iraq 3
NO - Norvegia 3
AR - Argentina 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
CL - Cile 2
KZ - Kazakistan 2
MU - Mauritius 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CR - Costa Rica 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
ZA - Sudafrica 1
Totale 7.528
Salva come PNG Salva come JPEG
Città #
Chandler 546
Singapore 350
Dublin 304
Santa Clara 188
Beijing 185
Torino 171
Ashburn 153
Vienna 129
Fairfield 127
Ann Arbor 116
Turin 112
Nyköping 106
Houston 98
Milan 92
Columbus 89
Medford 77
Redwood City 76
Wilmington 74
Princeton 70
Jacksonville 68
Seattle 67
Woodbridge 56
Villeurbanne 52
Cambridge 51
Fremont 51
Lappeenranta 49
Rome 42
Dearborn 35
Guangzhou 34
Jakarta 34
Pisa 33
Munich 31
Dong Ket 27
Brussels 26
Chengdu 26
Hangzhou 26
New York 24
Boston 22
Shanghai 22
Boardman 21
Warsaw 21
Santa Monica 20
Mumbai 17
Toronto 17
Seoul 16
London 15
Norwalk 15
Bologna 13
Helsinki 13
Zhengzhou 12
Hebei 11
Moncalieri 11
Nanjing 11
Padova 11
San Diego 11
Cervignano Del Friuli 10
Chicago 10
Los Angeles 10
San Mauro Torinese 10
Naples 9
Parma 9
Washington 9
Atlanta 8
Baltimore 8
Bari 8
Cagliari 8
Dronten 8
Hefei 8
Hong Kong 8
Nanchang 8
Nürnberg 8
Palermo 8
Tokyo 8
Wuhan 8
Barcelona 7
Bengaluru 7
Carugate 7
Falls Church 7
Florence 7
Grugliasco 7
Malmö 7
Paris 7
Pune 7
Siena 7
Upper Marlboro 7
Verona 7
Amsterdam 6
Chennai 6
Genova 6
Guiyang 6
Limoges 6
Ottawa 6
San Francisco 6
Silver Spring 6
São Paulo 6
Taipei 6
Taranto 6
Bangkok 5
Catania 5
Cisano Bergamasco 5
Totale 4.402
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 622
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 431
Validation of the revised classification of cognitive and behavioural impairment in ALS 267
Validation of the Italian version of self-administered ALSFRS-R scale 267
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 238
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 217
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 187
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 158
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 157
The multistep hypothesis of ALS revisited: The role of genetic mutations 157
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 141
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 141
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 141
Influence of cigarette smoking on ALS outcome: A population-based study 137
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 134
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 129
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 122
Cognitive impairment across ALS clinical stages in a population-based cohort 116
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 113
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 108
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 96
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 96
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 95
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 94
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 91
NADPH oxidases 2 activation in patients with Parkinson's disease 86
EXECUTIVE DYSFUNCTION SCORE OF THE FRONTAL BEHAVIOR SYSTEM SCALE (FrSBe) IS INDEPENDENTLY RELATED TO ALS OUTCOME 84
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 82
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 77
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 74
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 74
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 71
ALS phenotype is influenced by age, sex, and genetics: A population-based study 69
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 69
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 68
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 68
Genetic architecture of ALS in Sardinia. 67
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 67
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 66
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 66
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 64
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 63
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 63
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 62
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 61
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 61
GBA variants influence cognitive status in amyotrophic lateral sclerosis 60
Alcohol consumption and the risk of amyotrophic lateral sclerosis 59
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 59
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 59
Friedreich's ataxia patients and caregivers information seeking behaviour 58
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 58
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 57
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 55
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 54
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 53
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia 49
Deep learning methods to predict amyotrophic lateral sclerosis disease progression 48
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 46
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 46
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 45
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 44
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 42
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 42
Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis 40
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 39
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 38
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 37
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 37
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 36
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 36
What is amyotrophic lateral sclerosis prevalence? 35
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients 33
Brain 18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations 33
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 32
Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review 30
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis 29
Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis 28
Systematic evaluation of genetic mutations in ALS: a population-based study 27
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis 26
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol 24
Factors predicting disease progression in C9ORF72 ALS patients 24
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis 24
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 23
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis 23
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants 23
Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS) 21
Can amyotrophic lateral sclerosis progression really pause? A cohort study using the medical research council scale 21
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study 20
The role of peripheral immunity in ALS: a population-based study 19
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis 18
C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients 18
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant 18
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 17
High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants 17
Mycotoxins and Amyotrophic Lateral Sclerosis: food exposure, nutritional implications and dietary solutions 15
A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington's disease 13
Resting-state fMRI functional connectome of C9orf72 mutation status 13
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis 10
Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers 6
Totale 7.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.544
article - articoli 0
book - libri 0
conference - conferenze 1.784
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020530 0 0 0 0 24 75 75 74 95 104 43 40
2020/2021844 47 61 53 41 57 69 75 93 127 69 33 119
2021/20221.078 51 17 58 87 79 74 67 53 55 92 263 182
2022/20231.668 182 153 41 127 159 390 109 107 181 63 95 61
2023/20241.221 156 185 85 72 78 117 92 72 18 117 104 125
2024/20251.146 50 198 122 288 488 0 0 0 0 0 0 0
Totale 7.759